BlackRock’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $210K | Sell |
|
|||||
|
2022
Q3 | $688K | Buy |
|
|||||
|
2022
Q2 | $1.21M | Sell |
|
|||||
|
2022
Q1 | $19.3M | Buy |
|
|||||
|
2021
Q4 | $33.7M | Sell |
|
|||||
|
2021
Q3 | $62.3M | Buy |
|
|||||
|
2021
Q2 | $83.9M | Sell |
|
|||||
|
2021
Q1 | $96.4M | Buy |
|
|||||
|
2020
Q4 | $24.6M | Sell |
|
|||||
|
2020
Q3 | $16.5M | Sell |
|
|||||
|
2020
Q2 | $20M | Buy |
|
|||||
|
2020
Q1 | $13.4M | Sell |
|
|||||
|
2019
Q4 | $29.5M | Sell |
|
|||||
|
2019
Q3 | $24.9M | Buy |
|
|||||
|
2019
Q2 | $44M | Buy |
|
|||||
|
2019
Q1 | $48.2M | Buy |
|
|||||
|
2018
Q4 | $39.1M | Buy |
|
|||||
|
2018
Q3 | $38.2M | Buy |
|